Rheumatology Rundown: Vaccinations in JIA; RA and T2D; SLE Quality of Life
August 1st 2021The latest news in rheumatology includes the need for robust vaccinations in juvenile idiopathic arthritis; new findings about rheumatoid arthritis (RA) and type 2 diabetes; and quality of life in systemic lupus erythematosus.
Positive Results From SEQUOIA Analyses for Zanubrutinib in Treatment-Naive CLL and SLL
July 31st 2021In an interim analyses of the phase 3 SEQUOIA trial, zanubrutinib had superior progression-free survival compared with bendamustine plus rituximab in patients with treatment-naive chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL).
Reactivation of Hepatitis B After Ruxolitinib for MPN Hinges on Antivirals
July 24th 2021The issue of reactivating hepatitis B and other chronic viruses such as herpes zoster after treatment for myeloproliferative neoplasms (MPN) is an emerging issue in hematologic malignancies, due to the power of newer therapies.
What We’re Reading: Misinformation as Public Health Threat; LA Mask Mandate; COVID-19 Booster Debate
July 16th 2021An advisory from the US Surgeon General classifies COVID-19 misinformation as a public health threat; the most populous county in the nation reinstates a mask mandate; debate continues around COVID-19 booster shots.